Workflow
莲花健康(600186) - 2024 Q3 - 季度财报
600186LHG(600186)2024-10-30 10:02

Financial Performance - The company's operating revenue for Q3 2024 reached ¥712,985,982.04, representing an increase of 11.28% year-over-year[2] - Net profit attributable to shareholders was ¥64,302,644.59, a significant increase of 44.72% compared to the same period last year[2] - The basic earnings per share for the current period was ¥0.0921, reflecting a growth of 44.76%[2] - Total operating revenue for the first three quarters of 2024 reached ¥1,934,560,124.85, an increase of 19.8% compared to ¥1,614,339,467.07 in the same period of 2023[16] - Net profit for the first three quarters of 2024 was ¥167,328,623.53, compared to ¥96,843,503.27 in 2023, reflecting a growth of 73.1%[17] - The total comprehensive income for the first three quarters was ¥167,324,581.28, compared to ¥96,843,503.27 in 2023, showing a growth of 73.0%[18] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥3,262,490,209.07, marking a 33.95% increase from the previous year-end[3] - The company's total liabilities increased to ¥1,756,870,992.94 from ¥1,107,389,422.48, marking a rise of 58.7%[15] - The total equity attributable to shareholders of the parent company rose to ¥1,713,607,921.76, up from ¥1,538,472,106.84, an increase of 11.4%[15] - The company reported a significant increase in long-term equity investments, which decreased to RMB 8.91 million from RMB 28.13 million, indicating a decline of approximately 68.4%[13] Cash Flow - Cash flow from operating activities for the year-to-date reached ¥307,053,475.66, indicating a substantial increase of 301.85%[2] - The cash flow from operating activities for the first three quarters was not detailed, but the overall financial health appears to be improving based on net profit growth[17] - In the first three quarters of 2024, the cash inflow from operating activities reached ¥2,187,668,365.85, compared to ¥1,843,964,602.73 in the same period of 2023, representing an increase of approximately 18.6%[20] - The net cash flow from operating activities for the first three quarters of 2024 was ¥307,053,475.66, a significant increase from ¥76,409,887.00 in 2023[20] - The cash flow from financing activities in Q3 2024 included cash received from borrowings amounting to ¥576,705,000.00, which was a significant source of liquidity for the company[21] Investments and Expenses - Research and development expenses rose by 63.90%, reflecting increased investment in new product development[7] - The company's research and development expenses increased to ¥23,341,085.49 from ¥14,240,968.98, reflecting a growth of 64.1%[16] - The total cash outflow from investing activities in the first three quarters of 2024 was ¥638,124,863.81, compared to ¥43,950,728.55 in the same period of 2023, indicating a substantial increase in investment expenditures[20] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 103,633[8] - The company reported a basic earnings per share of ¥0.0921 for 2024, compared to ¥0.0527 in 2023, indicating a significant improvement[18] Operational Efficiency - The weighted average return on equity increased by 1.08 percentage points to 4.09% for the current period[3] - The company has seen an increase in accounts payable, which rose to ¥100,865,873.97 from ¥82,665,287.68, indicating a 21.5% increase[15] - The cash paid for purchasing goods and services in the first three quarters of 2024 was ¥1,619,257,096.20, slightly higher than ¥1,565,707,625.34 in 2023, indicating a growth of about 3.4%[20] Accounts Receivable and Inventory - The company reported a 40.70% increase in accounts receivable, driven by higher sales volume[7] - Accounts receivable rose to RMB 145.56 million, compared to RMB 103.46 million in the previous period, marking an increase of approximately 40.6%[11] - Inventory decreased to RMB 118.97 million from RMB 139.15 million, showing a decline of about 14.5%[13] Future Outlook - The company has not disclosed any new product launches or technological advancements in this quarter[10] - There are no significant mergers or acquisitions reported during this period[10] - The company has not provided specific future guidance or market expansion strategies in the current report[10]